A role for cell cycle proteins in the serum-starvation resistance of Epstein-Barr virus immortalized B lymphocytes

Biochemistry and Cell Biology

Volumn 80, Issue 4, 2002, Pages 407-413

  Kim, Hak Ryul ^a   Jeong, Ju Ah ^a   Park, Chan Hee ^a   Lee, Suk Kyeong ^a   Lee, Won Keun ^a   Jang, Yong Suk ^a  

^a Chonbuk National University   (South Korea)

Author keywords

B lymphocyte; Cell cycle proteins; Epstein Barr virus; Lymphoblastoid cell line; Serum starvation

Indexed keywords

CYTOLOGY; PROTEINS; TUMORS; VIRUSES;

SERUM STARVATION;

BIOCHEMISTRY;

CELL CYCLE PROTEIN; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P107; PROTEIN P130; PROTEIN P21; PROTEIN P27;

ARTICLE; B LYMPHOCYTE; CANCER PATIENT; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; NONHUMAN; SERUM; STARVATION; WESTERN BLOTTING;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 0036434730     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o02-085     Document Type: Article

References (37)

1. Allday, M.J., Sinclair, A., Parker, G., Crawford, D.H., and Farrell, P.J. 1995. Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J. 14: 1382-1391.
2. Arvanitakis, L., Yaseen, N., and Sharma, S. 1995. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. J. Immunol. 155: 1047-1056.
3. Balasubramanian, S., Ahmad, N., Jeedigunta, S., and Mukhtar, H. 1998. Alterations in cell cycle regulation in mouse skin tumors. Biochem. Biophys. Res. Commun. 243: 744-748.
4. Bissonnette, N., and Hunting, D.J. 1998. p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene, 16: 3461-3469.
5. Cannell, E.J., Farrell, P.J., and Sinclair, A.J. 1996. Epstein-Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B-cells. Oncogene, 13: 1413-1421.
6. Chen, W., Huang, S., and Cooper, N.R. 1998. Levels of p53 in Epstein-Barr virus-infected cells determine cell fate: Apoptosis, cell cycle arrest at the G1/S boundary without apoptosis, cell cycle arrest at the G2/M boundary without apoptosis, or unrestricted proliferation. Virology, 251: 217-226.
7. Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18: 1571-1583.
8. Cherney, B.W., Bhatia, K., and Tosato, G. 1994. A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells. Proc. Natl. Acad. Sci. U.S.A. 91: 12 967 -12 971.
9. EI-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, E., Kinzler, K.W., and Vogelstein, B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825.
10. Ewen, M.E., Xing, Y., Lawrence, J.B., and Livingston, D.M. 1991. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell, 66: 1155-1164.
11. Farrel, P.J. 1995. Epstein-Barr virus immortalizing genes. Trends Microbiol. 3: 105-109.
12. kip1 and degree of malignancy in human breast and colorectal cancers. Proc. Natl. Acad. Sci. U.S.A. 94: 6380-6385.
13. Fukami-Kobayashi, J., and Mitsui, Y. 1999. Overexpression of proliferating cell nuclear antigen in mammalian cells negates growth arrest by serum starvation and cell contact. Jpn. J. Cancer Res. 90: 286-293.
14. Grimm, S., Bauer, M.K., Baeuerle, P.A., and Schulze-Osthoff, K. 1996. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J. Cell Biol. 134: 13-23.
15. Hasan, N.M., Adams, G.E., and Joiner, M.C. 1998. Effect of serum starvation on expression and phosphorylation of PKC-alpha and p53 in V79 cells: Implications for cell death. Int. J. Cancer, 80: 400-405.
16. Hollyoake, M., Stuhler, A., Farrell, P., Gordon, J., and Sinclair, A. 1995. The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus. Cancer Res. 55: 4784-4787.
17. Hunter, T., and Pines, J. 1991. Cyclins and cancer. Cell, 66: 1071-1074.
18. Kip1) of cyclin-dependent kinase 4 activation. Cell, 79: 487-496.
19. Kawa, K. 2000. Epstein-Barr virus-associated diseases in humans. Int. J. Hematol. 71: 108-117.
20. Kip1. J. Pathol. 190: 604-612.
21. Kondo, T., Higashi, H., Nishizawa, H., Ishikawa, S., Ashizawa, S., Yamada, M., Makita, Z., Koike, T., and Hatakeyama, M. 2001. Involvement of pRB-related p107 protein in the inhibition of S phase progression in response to genotoxic stress. J. Biol. Chem. 276: 17 559-17 567.
22. LaBaer, J., Garrett, M.D., Stevenson, L.F., Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A., and Harlow, E. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11: 847-862.
23. Lee, W.K., Park, S.H., Kim, S.M., Kim, C.W., Sim, Y.S., Park, J.G., and Cho, S.G. 1998. B-lymphoblastoid cell lines from cancer patients. In Vitro Cell. Dev. Biol. Anim. 34: 97-100.
24. Li, Y., Graham, C., Lacy, S., Duncan, A.M.V., and Whyte, P. 1993. The adenovirus E1A associated 130-kD protein is encode by a member of the retinoblastoma gene family and physically interacts with cyclin A and E. Genes Dev. 7: 2366-2377.
25. Middleton, T., Gahn, T.A., Martin, J.M., and Sugden, B. 1991. Immortalizing genes of Epstein-Barr virus. Adv. Virus Res. 40: 19-55.
26. Nigg, E.A. 1993. Targets of cyclin-dependent protein kinases. Curr. Opin. Cell Biol. 5: 187-193.
27. O'Conner, R.J., Schaley, J.E., Feeney, G., and Hearing, P. 2001. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters. Oncogene, 20: 1882-1891.
28. Okano, M., and Gross, T.G. 2000. A review of Epstein-Barr virus infection in patients with immunodeficiency disorders. Am. J. Med. Sci. 319: 392-396.
29. Palmero, I., Holder, A., Sinclair, A.J., Dickson, C., and Peters, G. 1993. Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines. Oncogene, 8: 1049-1054.
30. Sherr, C.J., and Roberts, J.M. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9: 1149-1163.
31. Shim, J., Lee, H., Park, J., Kim, H., and Choi, E.J. 1996. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature (Lond.), 381: 804-807.
32. Sinclair, A.J., Palmero, I., Holder, A., Peters, G., and Farrell, P.J. 1995. Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene. J. Virol. 69: 1292-1295.
33. Spender, L.C., Cannell, E.J., Hollyoake, M., Wensing, B., Gawn, J.M., Brimmell, M., Packham, G., and Farrell, P.J. 1999. Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus. J. Virol. 73: 4678-4688.
34. Tam, S.W., Theodoras, A.M., Shay, J.W., Dratta, G.F., and Pagano, M. 1994. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: Association with Cdk4 is required for Cyclin D1 function in G1 progression. Oncogene, 9: 2663-2674.
35. Toyoshima, H., and Hunter, T. 1994. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell, 78: 67-74.
36. Wega, S., Hannon, G.J., Beach, D., and Stillman, D. 1994. The p21 cyclin-dependent kinase inhibitor directly controls DNA replication via interaction with PCNA. Nature (Lond.), 369: 574-578.
37. Yoshida, M., and Beppu, T. 1988. Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. Exp. Cell Res. 177: 122-131.